Session Type
Meeting
Search Results for Mortality
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Structured mortality review can help identify care issues and focus quality efforts, but existing methods have limitations. In the Department of Medicine at UCLA, we developed a novel in-person, near real-time, interdisciplinary rapid mortality review (RMR) process to capture the insight of frontline providers and improve care. In this study, we compare the yield […]
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Structured mortality review can help identify care issues and focus quality efforts, but existing methods have limitations. In the Department of Medicine at UCLA, we developed a novel in-person, near real-time, interdisciplinary rapid mortality review (RMR) process to capture the insight of frontline providers and improve care. In this study, we compare the yield […]
Abstract Number: 67
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Acute heart failure (AHF) is the major cause of hospital admission and death. Furthermore, patients admitted with AHF have high readmission rates and postdischarge mortality. Although there have been some reports, which demonstrated the predictive factors of death among patients of acute heart failure in the USA and Europe, there has been no studies […]
Abstract Number: 69
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Congestive heart failure (CHF) and pneumonia are amongst the leading causes of hospitalization in the United States. Although a growing number of hospitals use both teaching and nonteaching hospitalist services for patient care, the differences in clinical outcomes and efficiency between these two services is not clearly known. The aim of this study […]
Abstract Number: 73
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: The UCLA Department of Medicine (DOM) Rapid Mortality Review (RMR) is an innovative in-person, near real-time review of all deaths to capture the unique insight of the care providers into aspects of end-of-life care quality that otherwise go undocumented and unreported. The purpose of this study is to examine characteristics of mortality cases that […]
Abstract Number: 78
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: The randomized controlled ANZ-STATInS trial demonstrated that de novo statin use did not alter interleukin-6 levels or Sequential Organ Failure Assessment (SOFA) score in of what before SEPSIS-3 was known as severe sepsis. Prospective observational studies indicate that prior statin use sepsis is associated with a decreased rate of severe sepsis. We aimed to […]